Literature DB >> 33742407

In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer.

Marc Nunez-Olle1,2, Marc Guiu1,2, Roger R Gomis3,4,5,6.   

Abstract

Metastasis is the main cause of death for cancer patients, but our ability to improve clinical outcome first requires a better understanding of the dynamics, cellular mechanisms, and kinetics of metastasis. In prostate cancer (PCa), metastatic tumor cells preferentially colonize to bone. However, a lack of applicable mouse models has limited our ability to study this process accurately. Here, we describe a strategy to bypass this limitation: human PCa cells are injected into immunodeficient mice (at tibia, the left ventricle of heart and the iliac artery). Using this novel technique, the metastatic capabilities of these human PCa cells (e.g., colonization and proliferation potential) can be analyzed in bone with an in vivo imaging system.

Entities:  

Keywords:  Bone; In vivo imaging; Metastasis; Mouse model; Prostate cancer

Mesh:

Year:  2021        PMID: 33742407     DOI: 10.1007/978-1-0716-1350-4_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors:  Elena Castro; Nuria Romero-Laorden; Angela Del Pozo; Rebeca Lozano; Ana Medina; Javier Puente; Josep Maria Piulats; David Lorente; Maria Isabel Saez; Rafael Morales-Barrera; Enrique Gonzalez-Billalabeitia; Ylenia Cendón; Iciar García-Carbonero; Pablo Borrega; M José Mendez Vidal; Alvaro Montesa; Paz Nombela; Eva Fernández-Parra; Aránzazu Gonzalez Del Alba; José Carlos Villa-Guzmán; Kristina Ibáñez; Alejo Rodriguez-Vida; Lorena Magraner-Pardo; Begoña Perez-Valderrama; Elena Vallespín; Enrique Gallardo; Sergio Vazquez; Colin C Pritchard; Pablo Lapunzina; David Olmos
Journal:  J Clin Oncol       Date:  2019-01-09       Impact factor: 44.544

Review 3.  High-risk prostate cancer-classification and therapy.

Authors:  Albert J Chang; Karen A Autio; Mack Roach; Howard I Scher
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 4.  Faithfull modeling of PTEN loss driven diseases in the mouse.

Authors:  Caterina Nardella; Arkaitz Carracedo; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

Authors:  Nicholas D James; Johann S de Bono; Melissa R Spears; Noel W Clarke; Malcolm D Mason; David P Dearnaley; Alastair W S Ritchie; Claire L Amos; Clare Gilson; Rob J Jones; David Matheson; Robin Millman; Gerhardt Attard; Simon Chowdhury; William R Cross; Silke Gillessen; Christopher C Parker; J Martin Russell; Dominik R Berthold; Chris Brawley; Fawzi Adab; San Aung; Alison J Birtle; Jo Bowen; Susannah Brock; Prabir Chakraborti; Catherine Ferguson; Joanna Gale; Emma Gray; Mohan Hingorani; Peter J Hoskin; Jason F Lester; Zafar I Malik; Fiona McKinna; Neil McPhail; Julian Money-Kyrle; Joe O'Sullivan; Omi Parikh; Andrew Protheroe; Angus Robinson; Narayanan N Srihari; Carys Thomas; John Wagstaff; James Wylie; Anjali Zarkar; Mahesh K B Parmar; Matthew R Sydes
Journal:  N Engl J Med       Date:  2017-06-03       Impact factor: 91.245

6.  Metabolic syndrome increases the risk of aggressive prostate cancer detection.

Authors:  Juan Morote; Jordi Ropero; Jacques Planas; Juan M Bastarós; Gueisy Delgado; José Placer; Anna Celma; Inés M de Torres; Joan Carles; Jaume Reventós; Andreas Doll
Journal:  BJU Int       Date:  2012-08-09       Impact factor: 5.588

7.  Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

Authors:  Christopher J Sweeney; Yu-Hui Chen; Michael Carducci; Glenn Liu; David F Jarrard; Mario Eisenberger; Yu-Ning Wong; Noah Hahn; Manish Kohli; Matthew M Cooney; Robert Dreicer; Nicholas J Vogelzang; Joel Picus; Daniel Shevrin; Maha Hussain; Jorge A Garcia; Robert S DiPaola
Journal:  N Engl J Med       Date:  2015-08-05       Impact factor: 91.245

Review 8.  Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care.

Authors:  Fred Saad; Carl Olsson; Claude C Schulman
Journal:  Eur Urol       Date:  2004-12       Impact factor: 20.096

9.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

Review 10.  From latency to overt bone metastasis in breast cancer: potential for treatment and prevention.

Authors:  Fernando Salvador; Alicia Llorente; Roger R Gomis
Journal:  J Pathol       Date:  2019-06-27       Impact factor: 7.996

View more
  1 in total

1.  Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Authors:  Mireia Olivan; Marta Garcia; Leticia Suárez; Marc Guiu; Laura Gros; Olga Méndez; Marina Rigau; Jaume Reventós; Miguel F Segura; Inés de Torres; Jacques Planas; Xavier de la Cruz; Roger R Gomis; Juan Morote; Ruth Rodríguez-Barrueco; Anna Santamaria
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.